Detecting measurable residual disease beyond 10−4 by an IGHV leader-based NGS approach improves prognostic stratification in CLL
Paul J. Hengeveld(Erasmus MC), Anton W. Langerak(Erasmus MC), Lina van der Straten(Erasmus MC), Frédéric Davi(Sorbonne Université), Peter E. Westerweel(Cornell University), Michèle Y. van der Klift(Erasmus MC), Jorn L. J. C. Assmann(Erasmus MC), Kirsten Fischer(University of Cologne), P. Martijn Kolijn(Erasmus MC), Sandra Robrecht(University of Cologne), Matthias Ritgen(Goethe University Frankfurt), Valentin Goede(St. Marien Hospital), Evert de Jonge(Erasmus MC), François G. Kavelaars(Erasmus MC), Mark‐David Levin(Albert Schweitzer Ziekenhuis)
Cited by 24